1st NordiQC Conference on Standardization in Applied Immunohistochemistry

Size: px
Start display at page:

Download "1st NordiQC Conference on Standardization in Applied Immunohistochemistry 2013 1"

Transcription

1 Hotel Hvide Hus, Aalborg, 4 th 7 th June 2013 Prof. Mogens Vyberg, NordiQC director Serial sections stained for Estrogen receptor Breast cancers stained for Estrogen receptor Why?

2 Breast cancers stained for CK-HMW Breast cancers stained for CK-HMW CK5 34BE12 HIER+PROT Lab. C Lab. C 34BE12 HIER IHC quality problem Immunohistochemistry Staining patterns and quality varies between different laboratories - depending on the expertise and individual selection of reagents and methods Different antibodies, visualization systems, chromogenes, platforms and guide lines give different results Internal quality control will often not identify a poorly calibrated IHC system or varying quality of products giving insufficient or aberrant staining results External quality assessment is mandatory 9 Processing decalcification Tissue type, dimensions, biological variation (tumour dediff.) cauterization Interpretation quantification pos./neg. def. -cut-off level panels algorithms Sections thickness drying storage Fixation delay, time, type, volume Pre-treatment proteolysis, HIER, time, temp, ph Platform manual stainer type Visualization system sensitivity, specificity enhancement Reporting diagnostic context Control internal/external critical stain quality indicators Primary antibody clone, dilution buffer, time, temp Analytic Chromogene sensitivity, Immunohistochemistry External Quality Assessment Processing decalcification Tissue type, dimensions, biological variation (tumour dediff.) cauterization Fixation delay, time, type, volume Interpretation quantification pos./neg. def. -cut-off level panels algorithms Preanalytic Postanalytic Pre- EQA analytic Sections thickness drying stainer storage Postanalytic Pre-treatment proteolysis, HIER, time, temp, ph Platform manual type Visualization system sensitivity, specificity enhancement Reporting diagnostic context Control internal/external critical stain quality indicators Primary antibody clone, dilution buffer, time, temp Analytic Chromogene sensitivity, Nordic immunohistochemical Quality Control Founded 2003 by Nordic pathologists Independent, scientific, not-for-profit organisation Institute of Pathology, Aalborg University Hospital General module: 3 runs/year different markers Breast cancer IHC module: 2 runs HER-2, ER/PR, Ki/E-Cad HER-2 ISH module: 2 runs/year BRISH, FISH

3 NordiQC participants NordiQC Assessments ~ 40 countries Central assessment with consensus between experienced pathologists and histotechnologists Nordic countries Correlate staining results with central protocol parameters in order to identify Successful and less successful Abs Appropriate and inappropriate protocol settings Staining platform issues Reliable control tissues Publish general results on an open website: General Breast ca. IHC HER-2 ISH individual results to the participants Specific explanations for insufficient results Tailored recommendations for improvement 14 NordiQC Assessments Assessments > 50 runs = > 30,000 slides = > 150,000 tissue sections = > 1,500,000 bits of protocol info. Results of NordiQC recommendations 419 advices for 11 markers No. Improved % Positive Negative NordiQC EQA: Estrogen Receptor HER-2 staining results in 10 runs % articipants No. pa B1 B3 B5 B7 B8 B10 B RUN PASS RATE (%) No. OF PARTICIPANTS

4 Economic impact of HER-2 test inaccuracy IHC External Quality Assessment Application of NordiQC test results in an economic model for the US population (unpublished) Approved IVD Nonapproved IVD Total Number of tests 1145 (%) 558 (33%) 1703 Pooled FN + FP rates 11% 30% Total costs $M 14 $M 55 $M 69 About 30% of all IHC stains assessed by NordiQC are still insufficient! New labs New antibodies, techniques, platforms Increasing demands How many IHC stains produced by labs not participating in an EQA scheme are insufficient? How many scientific publications are based on insufficient IHC stains? 19 Optimized Ki staining how to count? Ki staining in two labs - no sense in counting ROI - Hotspot or average? Cut off for staining intensity? Enjoy your stay in Aalborg Hormone receptors HER-2 Ki Gene profiling in relation to IHC Mutation specific protein markers Haematopathology markers EQA programmes Central parameters in optimization / standardization Image analysis and stereology in relation to IHC Handouts are available on the website

5 KUNSTEN Museum of Modern Art Dinner in Robber s Camp Thursday Bus dept. 18:00 Name badges must be worn at all times Tickets presented at bus departure Reception Wednesday 18:00 19:30 Name badges must be worn at all times Icelandic artist Olafur Eliasson 25 Hotel Hvide Hus, Aalborg, 4 th 7 th June 2013 Prof. Mogens Vyberg, NordiQC director Welcome to Aalborg

Articles. Nordic Immunohistochemical Quality Control (NordiQC) - An Organization for External Quality Assurance. Mogens Vyberg, MD

Articles. Nordic Immunohistochemical Quality Control (NordiQC) - An Organization for External Quality Assurance. Mogens Vyberg, MD Articles Nordic Immunohistochemical Quality Control (NordiQC) - An Organization for External Quality Assurance Mogens Vyberg, MD Institute of Pathology. Aalborg Hospital Aarhus University Hospital Denmark

More information

PATHOLOGY. HercepTestTM. Product Information

PATHOLOGY. HercepTestTM. Product Information PATHOLOGY HercepTestTM Product Information CLINICAL TRIALS HercepTest The First and Foremost Dako s pharmdx HercepTest was the first FDA-approved assay developed exclusively to aid physicians in identifying

More information

HER2 Testing in Breast Cancer

HER2 Testing in Breast Cancer HER2 Testing in Breast Cancer GAIL H. VANCE, M.D. AGT MEETING JUNE 13, 2014 LOUISVILLE, KENTUCKY No Conflict of Interest to Report Human Epidermal Growth Factor Receptor 2-HER2 Human epidermal growth factor

More information

IHC Service Center. Department of Medicine

IHC Service Center. Department of Medicine Department of Medicine IHC Service Center Boston University School of Medicine 650 Albany Street, Room 431, 437, EBRC Boston, MA Phone: 617-638-7003 Fax: 617-638-7140 We are here to assist you with your

More information

A 70-year old Man with Pleural Effusion

A 70-year old Man with Pleural Effusion Mesothelioma Diagnosis: Pitfalls and Latest Updates S Klebe and DW Henderson Recommendations Indisputable malignant cells on cytomorphological criteria which demonstrate a mesothelial phenotype, which

More information

Clinical Histology Procedure Histo03.01 Automated Immunohistochemical Staining Utilizing the Ventana Benchmark Instrument

Clinical Histology Procedure Histo03.01 Automated Immunohistochemical Staining Utilizing the Ventana Benchmark Instrument Clinical Histology Procedure Histo03.01 Automated Immunohistochemical Staining Utilizing the Ventana Benchmark Instrument Final Approval: May 2010 Effective: May 2010 Next Review Date: May 2012 List all

More information

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Second Opinion in Breast Pathology Usually requested when a patient is referred

More information

Interpretation Guide for VENTANA anti-her2/neu (4B5)

Interpretation Guide for VENTANA anti-her2/neu (4B5) Interpretation Guide for VENTANA anti-her2/neu (4B5) Rabbit Monoclonal Primary Antibody Staining of Breast and Gastric Carcinoma E2451_1211C_HER2_4B5_Breast_and_Gastric_Interpretation_Guide-05.indd 1 Table

More information

March 19, 2014. Dear Dr. Duvall, Dr. Hambrick, and Ms. Smith,

March 19, 2014. Dear Dr. Duvall, Dr. Hambrick, and Ms. Smith, Dr. Daniel Duvall, Medical Officer Center for Medicare, Hospital and Ambulatory Policy Group Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, Maryland 21244 Dr. Edith Hambrick,

More information

ab176915 StayBlue/AP Plus Stain Kit Instructions for Use An immunohistochemical chromogen substrate for staining tissue sections

ab176915 StayBlue/AP Plus Stain Kit Instructions for Use An immunohistochemical chromogen substrate for staining tissue sections ab176915 StayBlue/AP Plus Stain Kit Instructions for Use An immunohistochemical chromogen substrate for staining tissue sections This product is for research use only and is not intended for diagnostic

More information

Clinical Histology Procedure histo13.01 Automated Immunohistochemical Staining Utilizing the Bond III Instrument

Clinical Histology Procedure histo13.01 Automated Immunohistochemical Staining Utilizing the Bond III Instrument Clinical Histology Procedure histo13.01 Automated Immunohistochemical Staining Utilizing the Bond III Instrument Final Approval: October 2010 Effective: October 2010 Next Review Date: February 2013 List

More information

Receptor conversion in distant breast cancer metastases. Breast cancer metastases: A spitting image of their primary?

Receptor conversion in distant breast cancer metastases. Breast cancer metastases: A spitting image of their primary? Receptor conversion in distant breast cancer metastases Breast cancer metastases: A spitting image of their primary? Introduction Breast cancer is the leading cause of female cancer death worldwide (13,000

More information

VENTANA Digital Pathology. Reliable. Efficient. Comprehensive.

VENTANA Digital Pathology. Reliable. Efficient. Comprehensive. VENTANA Digital Pathology Reliable. Efficient. Comprehensive. In the quest to improve the lives of all patients afflicted with cancer, every second counts. Fast, informed clinical decisions are essential

More information

Immunohistochemistry. Services & Products. Indivumed GmbH Falkenried 88, Bldg. D 20251 Hamburg Germany

Immunohistochemistry. Services & Products. Indivumed GmbH Falkenried 88, Bldg. D 20251 Hamburg Germany Services & Products Indivumed GmbH Falkenried 88, Bldg. D 20251 Hamburg Germany Phone Europe: +49-40-41 33 83-0 Fax Europe: +49-40-41 33 83-14 Phone USA: +1-301-588-4650 [email protected] www.indivumed.com

More information

10/06/2013. Commentary. The best way to achieve optimal treatment of today s patients is to ensure the availability of

10/06/2013. Commentary. The best way to achieve optimal treatment of today s patients is to ensure the availability of With main focus on the Estrogen Receptor Commentary The best way to achieve optimal treatment of today s patients is to ensure the availability of reliableand timelypathological th l i l assessment in

More information

Regulatory Issues in Genetic Testing and Targeted Drug Development

Regulatory Issues in Genetic Testing and Targeted Drug Development Regulatory Issues in Genetic Testing and Targeted Drug Development Janet Woodcock, M.D. Deputy Commissioner for Operations Food and Drug Administration October 12, 2006 Genetic and Genomic Tests are Types

More information

FULLY AUTOMATED PARALLEL DUAL STAINING DETECTION SYSTEM. ChromoPlex 1 Dual Detection for BOND

FULLY AUTOMATED PARALLEL DUAL STAINING DETECTION SYSTEM. ChromoPlex 1 Dual Detection for BOND ChromoPlex 1 Dual Detection for BOND FULLY AUTOMATED PARALLEL DUAL STAINING DETECTION SYSTEM View multiple antibodies on a single slide to deliver a comprehensive clinical result. 1 MULTIPLY YOUR CAPABILITIES

More information

How To Use Calretinin

How To Use Calretinin Product Code: MP-092-CR01 (0.1ml concentrate) MP-092-CR05 (0.5ml concentrate) MP-092-CR1 (1ml concentrate) MP-092-PR6 (6ml RTU) Product Description: Calretinin Concentrated and Prediluted Polyclonal Antibody

More information

Development and Validation of In Vitro Diagnostic Tests. YC Lee, Ph.D. CEO

Development and Validation of In Vitro Diagnostic Tests. YC Lee, Ph.D. CEO Development and Validation of In Vitro Diagnostic Tests YC Lee, Ph.D. CEO 1 Validation of In Vitro Diagnostic Tests Validated d Diagnostic Test should: Provides test results that identify if positive i

More information

micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved

micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved microrna 2 micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved Regulate gene expression by binding complementary regions at 3 regions of target mrnas Act as negative

More information

BREAST CANCER PATHOLOGY

BREAST CANCER PATHOLOGY BREAST CANCER PATHOLOGY FACT SHEET Version 4, Aug 2013 This fact sheet was produced by Breast Cancer Network Australia with input from The Royal College of Pathologists of Australasia I m a nurse and know

More information

JOINT COMMISSION INTERNATIONAL ACCREDITATION STANDARDS FOR. 2nd Edition

JOINT COMMISSION INTERNATIONAL ACCREDITATION STANDARDS FOR. 2nd Edition JOINT COMMISSION INTERNATIONAL ACCREDITATION STANDARDS FOR CliniCAl laboratories 2nd Edition Effective 1 April 2010 International Patient Safety Goals (IPSG) Goals The following is a list of all goals.

More information

How To Use A Breast Cancer Test To Help You Choose Chemotherapy

How To Use A Breast Cancer Test To Help You Choose Chemotherapy Gene expression profiling and expanded immunohistochemistry tests for guiding adjuvant chemotherapy decisions in early breast cancer management: MammaPrint, Oncotype DX, IHC4 and Mammostrat Issued: September

More information

Laboratory Testing for Her2 Status in Breast Cancer

Laboratory Testing for Her2 Status in Breast Cancer Laboratory Testing for Her2 Status in Breast Cancer Katherine Geiersbach, M.D. Assistant Professor, Department of Pathology May 28, 2015 Overview Clinical relevance of Her2 status for treatment of breast

More information

Practical Effusion Cytology

Practical Effusion Cytology Practical Effusion Cytology A Community Pathologist s Approach to Immunocytochemistry in Body Fluid Cytology Emily E. Volk, MD William Beaumont Hospital Troy, MI College of American Pathologists 2004.

More information

Sutter Health Support Services Shared Laboratory Position Description. Incumbent: Laboratory Date: October 23, 2006 Written By: Michele Leonard

Sutter Health Support Services Shared Laboratory Position Description. Incumbent: Laboratory Date: October 23, 2006 Written By: Michele Leonard Sutter Health Support Services Shared Laboratory Position Description Position Title: Clinical Laboratory Scientist, Microbiologist Incumbent: Entity: SHSS Shared Laboratory Reports To: Director of Operations,

More information

How To Get A Cell Print

How To Get A Cell Print QUICK CELL CAPTURE AND CHARACTERIZATION GUIDE FOR CELLSEARCH CUSTOMERS CellSave EDTA Blood sample Rare cell capture Enumeration Single protein marker Cell capture for molecular characterization CELLSEARCH

More information

SMF Awareness Seminar 2014

SMF Awareness Seminar 2014 SMF Awareness Seminar 2014 Clinical Evaluation for In Vitro Diagnostic Medical Devices Dr Jiang Naxin Health Sciences Authority Medical Device Branch 1 In vitro diagnostic product means Definition of IVD

More information

Fixation and Other Pre-Analytical Factors

Fixation and Other Pre-Analytical Factors Part I: The Staining Process Chapter 2 Fixation and Other Pre-Analytical Factors Elizabeth C. Colley, MLT, ART Ronald H. Stead, PhD, FRCPath Pre-an a lyt i cal (n.) Describing any variable whose value

More information

HER2 Status: What is the Difference Between Breast and Gastric Cancer?

HER2 Status: What is the Difference Between Breast and Gastric Cancer? Ask the Experts HER2 Status: What is the Difference Between Breast and Gastric Cancer? Bharat Jasani MBChB, PhD, FRCPath Marco Novelli MBChB, PhD, FRCPath Josef Rüschoff, MD Robert Y. Osamura, MD, FIAC

More information

Your Guide to the Breast Cancer Pathology Report

Your Guide to the Breast Cancer Pathology Report Your Guide to the Breast Cancer Pathology Report Developed for you by Breastcancer.org is a nonprofit organization dedicated to providing education and information on breast health and breast cancer. The

More information

Product Datasheet and Instructions for Use

Product Datasheet and Instructions for Use Product Code: MP-378-CMK01 (0.1ml conc) MP-378-CMK05 (0.5ml conc) MP-378-PM6 (6ml RTU) Product Description: CD141 (Thrombomodulin) Concentrated and Prediluted Monoclonal Antibody Control Number: 901-378-071709

More information

Outline. 1. Experiment. 2. Sample analysis and storage. 3. Image analysis and presenting data. 4. Probemaker

Outline. 1. Experiment. 2. Sample analysis and storage. 3. Image analysis and presenting data. 4. Probemaker Tips and tricks Note: this is just an informative document with general recommendations. Please contact [email protected] should you have any queries. Document last reviewed 2011-11-17 Outline 1. Experiment

More information

IHC Nuclear Image Analysis. User s Guide

IHC Nuclear Image Analysis. User s Guide IHC Nuclear Image Analysis User s Guide Copyright 2007 Aperio Technologies, Inc. Part Number/Revision: MAN-0027, Revision B Date: January 2, 2007 This document applies to software versions Release 8.0

More information

EDUCATION. HercepTest TM. Interpretation Manual Breast Cancer

EDUCATION. HercepTest TM. Interpretation Manual Breast Cancer EDUCATION HercepTest TM Interpretation Manual Breast Cancer EDUCATION HercepTest TM Table of Contents Contents 5 Introduction 6 HER2 Overview 6 HER2 Protein and HER2 Family 6 HER2 Testing IHC and FISH

More information

HER2. Improved Quality and Efficiency FISH. HER2 IQFISH pharmdx

HER2. Improved Quality and Efficiency FISH. HER2 IQFISH pharmdx WHI T E PAP E R FISH HER2 IQFISH pharmdx HER2 IQFISH pharmdx HER2 IQFISH pharmdx Improved Quality and Efficiency Improved Quality and Efficiency Debra S. Cohen, BS, CG(ASCAP)CM & Sharon Alsobrook, CG(ASCP)CM,

More information

DETERMINATION OF HER2 STATUS IN BREAST CANCER PATIENTS BY TWO METHODS: REAL-TIME QUANTITATIVE PCR (QPCR) AND IMMUNOENZIMATIC ASSAY (EIA)

DETERMINATION OF HER2 STATUS IN BREAST CANCER PATIENTS BY TWO METHODS: REAL-TIME QUANTITATIVE PCR (QPCR) AND IMMUNOENZIMATIC ASSAY (EIA) DETERMINATION OF HER2 STATUS IN BREAST CANCER PATIENTS BY TWO METHODS: REAL-TIME QUANTITATIVE PCR (QPCR) AND IMMUNOENZIMATIC ASSAY (EIA) Maria Savino, Paola Parrella, Massimiliano Copetti, Raffaela Barbano,

More information

BioPATH: A Study of Biomarker Profiles in Asia Pacific HER2 Breast Cancer Patients Treated with Lapatinib and Other Anti-HER2 Therapy

BioPATH: A Study of Biomarker Profiles in Asia Pacific HER2 Breast Cancer Patients Treated with Lapatinib and Other Anti-HER2 Therapy BioPATH: A Study of Biomarker Profiles in Asia Pacific HER2 Breast Cancer Patients Treated with Lapatinib and Other Anti-HER2 Therapy Soonmyung Paik 1 ; Gyungyub Gong 2 ; Yap Yoon Sim 3 ; Tae- You Kim

More information

Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Biochemistry

Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Biochemistry Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Biochemistry The Master Degree in Medical Laboratory Sciences /Clinical Biochemistry, is awarded by the Faculty of Graduate Studies

More information

Bronson Methodist Hospital: A systematic approach to validating xylene free processing on the Leica PELORIS tissue processor.

Bronson Methodist Hospital: A systematic approach to validating xylene free processing on the Leica PELORIS tissue processor. Bronson Methodist Hospital: A systematic approach to validating xylene free processing on the Leica PELORIS tissue processor. In 2010, the pathology laboratory at Bronson Methodist Hospital (BMH) in Kalamazoo,

More information

1.Gene Synthesis. 2.Peptide & Phospho-P. Assembly PCR. Design & Synthesis. Advantages. Specifications. Advantages

1.Gene Synthesis. 2.Peptide & Phospho-P. Assembly PCR. Design & Synthesis. Advantages. Specifications. Advantages 1.Gene Synthesis Assembly PCR Looking for a cdna for your research but could not fish out the gene through traditional cloning methods or a supplier? Abnova provides a gene synthesis service via assembly

More information

NAACLS Standards for Accredited and Approved Programs. Adopted 2012, Revised 9/2013, 1/2014, 4/2014, 10/2014, 11/2014

NAACLS Standards for Accredited and Approved Programs. Adopted 2012, Revised 9/2013, 1/2014, 4/2014, 10/2014, 11/2014 NAACLS Standards for Accredited and Approved Programs Adopted 2012, Revised 9/2013, 1/2014, 4/2014, 10/2014, 11/2014 Contents Core Standards... 1 I. Sponsorship... 1 II. Assessment and Continuous Quality

More information

IBCSG Tissue Bank Policy

IBCSG Tissue Bank Policy THE INTERNATIONAL BREAST CANCER STUDY GROUP IBCSG Tissue Bank Policy Accepted by the IBCSG Executive Committee on March 24, 2006 Accepted by the IBCSG Ethics Committee on March 24, 2006 Accepted by the

More information

TFE3 (MRQ-37) Rabbit Monoclonal Antibody PRODUCT AVAILABILITY SYMBOL DEFINITIONS INTENDED USE PRINCIPLES AND PROCEDURES SUMMARY AND EXPLANATION

TFE3 (MRQ-37) Rabbit Monoclonal Antibody PRODUCT AVAILABILITY SYMBOL DEFINITIONS INTENDED USE PRINCIPLES AND PROCEDURES SUMMARY AND EXPLANATION Rev. 0.0 TFE3 (MRQ-37) Rabbit Monoclonal Antibody PRODUCT AVAILABILITY Cat. No. Description 354R-14 0.1 ml, concentrate 354R-15 0.5 ml, concentrate 354R-16 1.0 ml, concentrate 354R-17 1.0 ml, predilute

More information

ab183294 TripleStain IHC Kit: M&M&R on rodent tissue (DAB, DAB/Ni & AP/Red)

ab183294 TripleStain IHC Kit: M&M&R on rodent tissue (DAB, DAB/Ni & AP/Red) ab183294 TripleStain IHC Kit: M&M&R on rodent tissue (DAB, DAB/Ni & AP/Red) Instructions for Use For the detection of Rabbit and Mouse Primary antibodies on Rodent Tissue. This product is for research

More information

BRCA and Breast/Ovarian Cancer -- Analytic Validity Version 2003-6 2-1

BRCA and Breast/Ovarian Cancer -- Analytic Validity Version 2003-6 2-1 ANALYTIC VALIDITY Question 8: Is the test qualitative or quantitative? Question 9: How often is a test positive when a mutation is present (analytic sensitivity)? Question 10: How often is the test negative

More information

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo, Finland 2nd Nordic Conference on Applied

More information

Measurement of HER2. Daniel F. Hayes, MD Clinical Director, Breast Oncology Program University of Michigan Comprehensive Cancer Center

Measurement of HER2. Daniel F. Hayes, MD Clinical Director, Breast Oncology Program University of Michigan Comprehensive Cancer Center Measurement of HER2 Daniel F. Hayes, MD Clinical Director, Breast Oncology Program University of Michigan Comprehensive Cancer Center Trastuzumab Metastatic Adjuvant Lapatinib Metastatic Trials Why Test

More information

Quality Requirements of a Point of Care Testing Service

Quality Requirements of a Point of Care Testing Service Quality Requirements of a Point of Care Testing Service Adil I. Khan MSc, PhD Assistant Professor of Pathology Director of Point of Care Testing & Clinical Chemistry Laboratory, Temple University Episcopal

More information

CANCER RESEARCH UK STRATIFIED MEDICINE PROGRAMME IAN WALKER PHD, MBA HEAD OF STRATIFIED MEDICINE

CANCER RESEARCH UK STRATIFIED MEDICINE PROGRAMME IAN WALKER PHD, MBA HEAD OF STRATIFIED MEDICINE CANCER RESEARCH UK STRATIFIED MEDICINE PROGRAMME IAN WALKER PHD, MBA HEAD OF STRATIFIED MEDICINE Agenda Introduction to Cancer Research UK CRUK Stratified Medicine Programme Key Challenges and Lessons

More information

Understanding your pathology report

Understanding your pathology report Understanding your pathology report 2 Contents Contents Introduction 3 What is a pathology report? 3 Waiting for your results 4 What s in a pathology report? 4 Information about your breast cancer 5 What

More information

IKDT Laboratory. IKDT as Service Lab (CRO) for Molecular Diagnostics

IKDT Laboratory. IKDT as Service Lab (CRO) for Molecular Diagnostics Page 1 IKDT Laboratory IKDT as Service Lab (CRO) for Molecular Diagnostics IKDT lab offer is complete diagnostic service to all external customers. We could perform as well single procedures or complex

More information

FDA Regulation of Whole Slide Imaging (WSI) Devices: Current Thoughts

FDA Regulation of Whole Slide Imaging (WSI) Devices: Current Thoughts FDA Regulation of Whole Slide Imaging (WSI) Devices: Current Thoughts Clinical Laboratory Improvement Advisory Committee Meeting Centers for Disease Control and Prevention February 15, 2012 Tremel A. Faison,

More information

FDA Regulation of Genetic Tests. Steven Gutman, M.D. Office of In Vitro Diagnostics

FDA Regulation of Genetic Tests. Steven Gutman, M.D. Office of In Vitro Diagnostics FDA Regulation of Genetic Tests Steven Gutman, M.D. Office of In Vitro Diagnostics Medical Device Amendments of 1976 General controls Registration and listing Good manufacturing practices Adverse event

More information

HER2 FISH pharmdx. Assay Kit

HER2 FISH pharmdx. Assay Kit PATHOLOGY HER2 FISH pharmdx Assay Kit HER2 FISH pharmdx Clarity You Can Count On Reliable Results at a Glance The robust HER2 FISH pharmdx assay offers bright and distinct signals for easy and fast reading

More information

KMS-Specialist & Customized Biosimilar Service

KMS-Specialist & Customized Biosimilar Service KMS-Specialist & Customized Biosimilar Service 1. Polyclonal Antibody Development Service KMS offering a variety of Polyclonal Antibody Services to fit your research and production needs. we develop polyclonal

More information

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

Outline. Workup for metastatic breast cancer. Metastatic breast cancer Metastatic breast cancer Immunostain Update: Diagnosis of metastatic breast carcinoma, emphasizing distinction from GYN primary 1/3 of breast cancer patients will show metastasis 1 st presentation or 20-30

More information

Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer

Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer J.-L. Zhang, Q. Yao, J.-H. Chen,Y. Wang, H. Wang, Q. Fan, R. Ling, J. Yi and L. Wang Xijing Hospital Vascular Endocrine

More information

Medical Laboratory Technology Program. Student Learning Outcomes & Course Descriptions with Learning Objectives

Medical Laboratory Technology Program. Student Learning Outcomes & Course Descriptions with Learning Objectives Medical Laboratory Technology Program Student Learning Outcomes & Course Descriptions with Learning Objectives Medical Laboratory Technology Student Learning Outcomes All Colorado Mesa University associate

More information

We Believe the Possibilities. Delphic AP

We Believe the Possibilities. Delphic AP We Believe the Possibilities. Delphic AP Designer Software for your pathology workflow. Delphic AP Tracks the specimen process cycle Labels cassettes and slides Enables sophisticated report creation Send

More information

Immunohistochemical classification of malignant lymphomas

Immunohistochemical classification of malignant lymphomas Immunohistochemical classification of malignant lymphomas Prof. Mogens Vyberg NordiQC Institute of Pathology Aalborg, Denmark Thanks to Jan Klos Important issues Distinction from non-hematopoietic neoplasms

More information

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY MALIGNANT MESOTHELIOMA CLASSIFICATION MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo,

More information

Your Guide to the Breast Cancer Pathology Report

Your Guide to the Breast Cancer Pathology Report Your Guide to the Breast Cancer Pathology Report Developed for you by Breastcancer.org is a nonprofit organization dedicated to providing education and information on breast health and breast cancer. The

More information

Standardisation of breast cancer pathology report. Gerd JACOMEN Pathology Breast Clinic AZ St Maarten Duffel/Mechelen Breast Clinic Voorkempen Malle

Standardisation of breast cancer pathology report. Gerd JACOMEN Pathology Breast Clinic AZ St Maarten Duffel/Mechelen Breast Clinic Voorkempen Malle Standardisation of breast cancer pathology report Gerd JACOMEN Pathology Breast Clinic AZ St Maarten Duffel/Mechelen Breast Clinic Voorkempen Malle Reporting BreastCa Pathology report = important tool

More information

Notes on titering antibodies

Notes on titering antibodies Home Events This Week Bulletin Boards Lab Personnel Lab Policies Protocols MolBio Tetramers Proteins Flow Cytometry Immunoassays Instruments Computers Lab Publications Scientiific Literature Science on

More information

Preparation "Clinical Laboratory Technologist and Technician Overview"

Preparation Clinical Laboratory Technologist and Technician Overview Clinical Laboratory Technologist and Technician Overview The Field - Preparation - Day in the Life - Earnings - Employment - Career Path Forecast - Professional Organizations The Field Clinical laboratory

More information

Digital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE

Digital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE Digital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE CRUK Stratified Medicine Initiative Somatic mutation testing for prediction of treatment response in patients with solid tumours:

More information

The Dako CoverStainer. t Vivantes. n Germany

The Dako CoverStainer. t Vivantes. n Germany The Dako CoverStainer t Vivantes n Germany B BY SOFIE KJÆRSGAARD HANSEN Better quality more consistency and increased speed The Dako CoverStainer entered the pathology laboratory of Vivantes in Berlin

More information

Human Luteinizing Hormone (LH) Custom Kit

Human Luteinizing Hormone (LH) Custom Kit Human Luteinizing Hormone (LH) Custom Kit 18089-v2-2015Jan 1 MSD Toxicology Assays Human Luteinizing Hormone (LH) Custom Kit This package insert must be read in its entirety before using this product.

More information

Tissue Cross-Reactivity of QRX-111 with Human, Cynomolgus Monkey and Rat Tissues in Vitro

Tissue Cross-Reactivity of QRX-111 with Human, Cynomolgus Monkey and Rat Tissues in Vitro Nova Pathology, PC Tissue Cross-Reactivity Pathology Report Tissue Cross-Reactivity of QRX-111 with Human, Cynomolgus Monkey and Rat Tissues Nova Pathology Study Number: NP-12-S-004 Testing Facility Study

More information

Principles of Immunohistochemistry Queen s Laboratory For Molecular Pathology

Principles of Immunohistochemistry Queen s Laboratory For Molecular Pathology Principles of Immunohistochemistry Queen s Laboratory For Molecular Pathology Table of Contents POLYCLONAL VERSUS MONOCLONAL ANTIBODIES...PAGE 3 DIRECT & INDIRECT ASSAYS.PAGE 4 LABELS..PAGE 5 DETECTION...PAGE

More information

The Diagnosis of Cancer in the Pathology Laboratory

The Diagnosis of Cancer in the Pathology Laboratory The Diagnosis of Cancer in the Pathology Laboratory Dr Edward Sheffield Christmas Select 74 Meeting, Queen s Hotel Cheltenham, 3 rd December 2014 Agenda Overview of the pathology of cancer How specimens

More information

OI PARP ΑΝΑΣΤΟΛΕΙΣ ΣΤΟΝ ΚΑΡΚΙΝΟ ΤΟΥ ΜΑΣΤΟΥ ΝΙΚΟΛΑΙΔΗ ΑΔΑΜΑΝΤΙΑ ΠΑΘΟΛΟΓΟΣ-ΟΓΚΟΛΟΓΟΣ Β ΟΓΚΟΛΟΓΙΚΗ ΚΛΙΝΙΚΗ ΝΟΣ. ΜΗΤΕΡΑ

OI PARP ΑΝΑΣΤΟΛΕΙΣ ΣΤΟΝ ΚΑΡΚΙΝΟ ΤΟΥ ΜΑΣΤΟΥ ΝΙΚΟΛΑΙΔΗ ΑΔΑΜΑΝΤΙΑ ΠΑΘΟΛΟΓΟΣ-ΟΓΚΟΛΟΓΟΣ Β ΟΓΚΟΛΟΓΙΚΗ ΚΛΙΝΙΚΗ ΝΟΣ. ΜΗΤΕΡΑ OI PARP ΑΝΑΣΤΟΛΕΙΣ ΣΤΟΝ ΚΑΡΚΙΝΟ ΤΟΥ ΜΑΣΤΟΥ ΝΙΚΟΛΑΙΔΗ ΑΔΑΜΑΝΤΙΑ ΠΑΘΟΛΟΓΟΣ-ΟΓΚΟΛΟΓΟΣ Β ΟΓΚΟΛΟΓΙΚΗ ΚΛΙΝΙΚΗ ΝΟΣ. ΜΗΤΕΡΑ Study Overview Inhibition of poly(adenosine diphosphate [ADP]-ribose) polymerase

More information

Ep-CAM/Epithelial Specific Antigen (MOC-31)

Ep-CAM/Epithelial Specific Antigen (MOC-31) Ep-CAM/Epithelial Specific Antigen (MOC- Product Identification Cat. No. Description 44588 EP-CAM 0,1 M (MOC- 44589 EP-CAM 1 M (MOC- 44283 EP-CAM RTU M (MOC- Symbol Definitions P C A E S DIL DOC# DIS ready-to-use

More information

Genetic testing. The difference diagnostics can make. The British In Vitro Diagnostics Association

Genetic testing. The difference diagnostics can make. The British In Vitro Diagnostics Association 6 Genetic testing The difference diagnostics can make The British In Vitro Diagnostics Association Genetic INTRODUCTION testing The Department of Health published Our Inheritance, Our Future - Realising

More information

USING CLSI GUIDELINES TO PERFORM METHOD EVALUATION STUDIES IN YOUR LABORATORY

USING CLSI GUIDELINES TO PERFORM METHOD EVALUATION STUDIES IN YOUR LABORATORY USING CLSI GUIDELINES TO PERFORM METHOD EVALUATION STUDIES IN YOUR LABORATORY Breakout Session 3B Tuesday, May 1 8:30 10 am James Blackwood, MS, CLSI David D. Koch, PhD, FACB, DABCC, Pathology & Laboratory

More information

Lung Carcinomas New 2015 WHO Classification. Spasenija Savic Pathology

Lung Carcinomas New 2015 WHO Classification. Spasenija Savic Pathology Lung Carcinomas New 2015 WHO Classification Spasenija Savic Pathology ***EXPECTED SPRING 2015*** This authoritative, concise reference book provides an international standard for oncologists and pathologists

More information

What is special about a stain, and why do we call some stains

What is special about a stain, and why do we call some stains Technical Articles Evolution of Use of Special Stains Alton D. Floyd, PhD Independent Consultant Edwardsburg, MI, USA What is special about a stain, and why do we call some stains special? We all think

More information

Helen Joseph Breast Care Clinic - Johannesburg, South Africa

Helen Joseph Breast Care Clinic - Johannesburg, South Africa - Johannesburg, South Africa General Information New breast cancer cases treated per year 360 Breast multidisciplinarity team members 12 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists

More information

P4 Distribution of Cetuximab in Models of Human Lung Cancer

P4 Distribution of Cetuximab in Models of Human Lung Cancer Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, University of Tübingen, Robert Bosch Foundation Stuttgart, Germany FORSYS Partner Project Predictive Cancer Therapy Project Meeting 14.10.09

More information

FRIEND TO FRIEND CPT CODES 2015 2016. Diagnostic digital breast tomosynthesis, unilateral (list separately in addition to code for primary procedure)

FRIEND TO FRIEND CPT CODES 2015 2016. Diagnostic digital breast tomosynthesis, unilateral (list separately in addition to code for primary procedure) FRIEND TO FRIEND CPT CODES 2015 2016 CPT CODE SERVICE DESCRIPTION FEE EFFECTIVE G0101 Screening pelvic examination $36.69 01 Jan 16 G0202 Mammography, screening, digital, bilateral (2 view film study of

More information

III II II 111111111111111111111111111111111111111111 1 1111111111111 III. ge: /ears sex: Male Access

III II II 111111111111111111111111111111111111111111 1 1111111111111 III. ge: /ears sex: Male Access UUID : 10F97F63 - EE6F-448D - 98E1-8AAA21F55753 TCGA - TS-A7PB-01A-PR Redacted III II II 111111111111111111111111111111111111111111 1 1111111111111 III Date Receive III 11111111111111111 11111111111 II

More information

Call 2014: High throughput screening of therapeutic molecules and rare diseases

Call 2014: High throughput screening of therapeutic molecules and rare diseases Call 2014: High throughput screening of therapeutic molecules and rare diseases The second call High throughput screening of therapeutic molecules and rare diseases launched by the French Foundation for

More information

Digital Pathology Image Analysis with Definiens

Digital Pathology Image Analysis with Definiens Understanding Images DEEPER INSIGHTS FASTER RESULTS BETTER DECISIONS Digital Pathology Image Analysis with Definiens 2,05 0,012 coexpression 10000 circularity infiltration biomarker intensity 48 mitotic

More information

Novocastra Liquid Mouse Monoclonal Antibody CD141 (Thrombomodulin)

Novocastra Liquid Mouse Monoclonal Antibody CD141 (Thrombomodulin) Novocastra Liquid Mouse Monoclonal Antibody CD141 (Thrombomodulin) Product Code: NCL-L-CD141 Leica Biosystems Newcastle Ltd Balliol Business Park West Benton Lane Newcastle Upon Tyne NE12 8EW United Kingdom

More information

Delphic AP. Designer software for your pathology workflow. We Believe the Possibilities.

Delphic AP. Designer software for your pathology workflow. We Believe the Possibilities. We Believe the Possibilities. Delphic AP Designer software for your pathology workflow. Sysmex Software Solutions. Shaping the advancement of healthcare. Delphic AP 1 Delphic AP Delphic AP has been specifically

More information

Parathyroid Hormone (PTH) (MRQ- 31)

Parathyroid Hormone (PTH) (MRQ- 31) Parathyroid Hormone (PTH) (MRQ- 31) Product Identification Cat. No. Description 44746 PTH 0,1 M (MRQ-31) 44747 PTH 1 M (MRQ-31) 44363 PTH RTU M (MRQ-31) Symbol Definitions P C A E S DIL DOC# DIS ready-to-use

More information

Immunohistochemistry of soft tissue tumors

Immunohistochemistry of soft tissue tumors Immunohistochemistry of soft tissue tumors Immunohistochemistry Major advances : antigen retrieval techniques (HIER) sensitive detection systems numerous antibodies of good quality Standardization : automated

More information

Urinalysis Compliance Tools. POCC Webinar January 19, 2011 Dr. Susan Selgren

Urinalysis Compliance Tools. POCC Webinar January 19, 2011 Dr. Susan Selgren Urinalysis Compliance Tools POCC Webinar January 19, 2011 Dr. Susan Selgren Learning Objectives Be able to review and improve upon a laboratory plan for compliance including: Competency Documentation Proficiency

More information